Effect of bioflavonoids on lysosomal acid hydrolases and lysosomal stability in adjuvant-induced arthritis. 1980

C N Rao, and V H Rao, and L Verbruggen, and S Orloff

In rats with adjuvant-induced arthritis, the effect of (+)-catechin (CA) and 0-(beta-hydroxyethyl) rutosides (HR) on the activity of certain lysosomal acid hydrolases, viz., beta-glucuronidase, beta-N-acetyl glucosaminidase and cathepsin D in serum, liver, kidney and spleen and the stability of liver lysosomes was studied. The activity of these enzymes in arthritic tissues and serum increased significantly. The total activity of beta-glucuronidase in the lysosome-rich fraction from arthritic liver was appreciably decreased, while its release was significantly increased. These results demonstrate the fragility of lysosomes in arthritic tissues. Administration of CA or HR to the arthritic animals was found to have a prophylactic action by stabilizing liver lysosomes and reducing the free lysosomal enzyme activities in serum, liver, kidney and spleen. CA was more effective than HR.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006867 Hydrolases Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3. Hydrolase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

C N Rao, and V H Rao, and L Verbruggen, and S Orloff
January 1980, The Italian journal of biochemistry,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
January 1987, The Italian journal of biochemistry,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
September 1997, Journal of ethnopharmacology,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
October 2020, Immunology letters,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
February 2015, Toxicology mechanisms and methods,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
November 1999, Molecular and cellular biochemistry,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
December 1974, Neurology India,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
May 1970, Annals of the rheumatic diseases,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
December 2011, Inflammopharmacology,
C N Rao, and V H Rao, and L Verbruggen, and S Orloff
March 1969, The Biochemical journal,
Copied contents to your clipboard!